Wall Street stocks edged higher Monday (May 19) after shrugging off a spike in US Treasury bond yields following Moody's ...

Regeneron Pharmaceuticals said in a press release yesterday that it would acquire 23andMe’s Personal Genome Service (PGS), ...

Dow Jones Top Company Headlines at 3 AM ET: Chinese Battery Giant CATL’s Shares Surge on Hong Kong Debut | Honda ... The listing comes as risk appetite has returned to global markets as trade ...

South San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Biotechnology company Regeneron agreed to buy the assets of 23andMe, the DNA testing company that filed for bankruptcy in March, for $256 million. That’s just 4% of the San Francisco-based startup’s ...

Regeneron, the Biotech company, has bought genetic testing company 23&Me for $256 million as the San Francisco-based company filed for bankruptcy in March of this year.

The measure given final approval by the state Senate and sent to Gov. Greg Abbott is dubbed the “The Uvalde Strong Act” and ...